Atlas Trials

Tislelizumab

25 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Tislelizumab

RecordFirmDate
Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC (NCT05394415)Jiangsu Cancer Institute & Hospital2022-05-01
Tislelizumab and Radiotherapy for Recurrent Cervical Cancer (NCT05310383)Lei Li2022-03-27
Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary (NCT05241132)Wei Xu2021-11-12
Phase II, Single-arm Exploratory Clinical Study of Tislelizumab Combined With Anlotinib in the Treatment of Advanced Pulmonary Pleomorphic Carcinoma (NCT05375734)Second Affiliated Hospital of Nanchang University2021-08-17
Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer (NCT04906044)The First Hospital of Jilin University2021-06-01
Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient (NCT07198217)Zibo Municipal Hospital2021-05-25
Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizumab and Lenvatinib in Patients With Advanced Unresectable Hepatocellular Carcinoma (NCT05131698)Cancer Hospital of Guangxi Medical University2021-03-01
Predictive Biomarker for Efficacy and Safety of Combination of Chemotherapy and Tislelizumab in NSCLC (NCT05244837)Hao Long2020-12-22
Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC (NCT06034964)Cancer Institute and Hospital, Chinese Academy of Medical Sciences2020-11-01

Track Tislelizumab automatically

Every clearance here is in the API, with alerts when new ones post.